ProAssurance Corporation (NYSE:PRA – Get Free Report) has earned a consensus recommendation of “Reduce” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $21.50.
PRA has been the subject of a number of analyst reports. Zacks Research upgraded shares of ProAssurance from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 20th. Wall Street Zen initiated coverage on shares of ProAssurance in a report on Monday, May 19th. They set a “hold” rating for the company.
Get Our Latest Stock Report on ProAssurance
Institutional Inflows and Outflows
ProAssurance Stock Up 0.1%
Shares of NYSE:PRA opened at $23.79 on Thursday. ProAssurance has a one year low of $12.43 and a one year high of $24.14. The company has a 50 day moving average of $23.79 and a 200-day moving average of $22.38. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.26 and a quick ratio of 0.26. The stock has a market cap of $1.22 billion, a price-to-earnings ratio of 25.30 and a beta of 0.12.
ProAssurance (NYSE:PRA – Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The insurance provider reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.33. The firm had revenue of $271.94 million during the quarter, compared to analysts’ expectations of $266.72 million. ProAssurance had a net margin of 4.33% and a return on equity of 5.62%. The business’s revenue for the quarter was down 19.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.23 earnings per share. On average, sell-side analysts forecast that ProAssurance will post 0.8 earnings per share for the current year.
About ProAssurance
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
See Also
- Five stocks we like better than ProAssurance
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Big Dividend Hikes Hit the Market—1 Just Doubled Its Payout
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- What NVIDIA’s Big Bet on Rival Quantinuum Means for D-Wave Stock
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Undervalued Stocks Poised to Shine in the Next Market Rally
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.